Search

Your search keyword '"Bradley, Walter"' showing total 712 results
Start Over Author "Bradley, Walter"
712 results on '"Bradley, Walter"'

2. Subcutaneous epcoritamab (SC epcor) administered outpatient (outpt) for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): Results from phase 2 EPCORE NHL-6.

Author

Andorsky, David Jacob, primary, Boccia, Ralph V., additional, Lash, Bradley Walter, additional, Vaidya, Rakhee, additional, Gandhi, Mitul, additional, Patel, Ameet, additional, Ibrahimi, Sami, additional, Vargas Madueno, Fernando Manuel, additional, Lee, Christina Y., additional, Naik, Seema, additional, Haydu, J. Erika, additional, Fesler, Mark, additional, Osei-Bonsu, Kojo, additional, Conte, Kristin, additional, Doerr, Thomas, additional, Bai, Yang, additional, Sacchi, Mariana, additional, and Sharman, Jeff Porter, additional

Published
2024
Full Text
View/download PDF

6. The Pluto Energetic Particle Spectrometer Science Investigation (PEPSSI) on the New Horizons Mission

Author

McNutt, Jr., Ralph L., Livi, Stefano A., Gurnee, Reid S., Hill, Matthew E., Cooper, Kim A., Andrews, G. Bruce, Keath, Edwin P., Krimigis, Stamatios M., Mitchell, Donald G., Tossman, Barry, Bagenal, Fran, Boldt, John D., Bradley, Walter, Devereux, William S., Ho, George C., Jaskulek, Stephen E., LeFevere, Thomas W., Malcom, Horace, Marcus, Geoffrey A., Hayes, John R., Moore, G. Ty, Williams, Bruce D., Wilson IV, Paul, Brown, L. E., Kusterer, M., and Vandegriff, J.

Subjects
Astrophysics
Abstract

The Pluto Energetic Particle Spectrometer Science Investigation (PEPSSI) comprises the hardware and accompanying science investigation on the New Horizons spacecraft to measure pick-up ions from Pluto's outgassing atmosphere. To the extent that Pluto retains its characteristics similar to those of a "heavy comet" as detected in stellar occultations since the early 1980s, these measurements will characterize the neutral atmosphere of Pluto while providing a consistency check on the atmospheric escape rate at the encounter epoch with that deduced from the atmospheric structure at lower altitudes by the ALICE, REX, and SWAP experiments on New Horizons. In addition, PEPSSI will characterize any extended ionosphere and solar wind interaction while also characterizing the energetic particle environment of Pluto, Charon, and their associated system. First proposed for development for the Pluto Express mission in September 1993, what became the PEPSSI instrument went through a number of development stages to meet the requirements of such an instrument for a mission to Pluto while minimizing the required spacecraft resources. The PEPSSI instrument provides for measurements of ions (with compositional information) and electrons from 10s of keV to ~1 MeV in a 120 deg x 12 deg fan-shaped beam in six sectors for 1.5 kg and ~2.5 W., Comment: 107 pages, 38 figures, 29 tables; To appear in a special volume of Space Science Reviews on the New Horizons mission

Published
2007
Full Text
View/download PDF

7. Validation of 13 Hot and Potentially Terrestrial TESS Planets

Author

Steven Giacalone, Courtney D. Dressing, Christina Hedges, Veselin B. Kostov, Karen A. Collins, Eric L. N. Jensen, Daniel A. Yahalomi, Allyson Bieryla, David R. Ciardi, Steve B. Howell, Jorge Lillo-Box, Khalid Barkaoui, Jennifer G. Winters, Elisabeth Matthews, John H. Livingston, Samuel N. Quinn, Boris S. Safonov, Charles Cadieux, E. Furlan, Ian J. M. Crossfield, Avi M. Mandell, Emily A. Gilbert, Ethan Kruse, Elisa V. Quintana, George R. Ricker, S. Seager, Joshua N. Winn, Jon M. Jenkins, Britt Duffy Adkins, David Baker, Thomas Barclay, David Barrado, Natalie M. Batalha, Alexander A. Belinski, Zouhair Benkhaldoun, Lars A. Buchhave, Luca Cacciapuoti, David Charbonneau, Ashley Chontos, Jessie L. Christiansen, Ryan Cloutier, Kevin I. Collins, Dennis M. Conti, Neil Cutting, Scott Dixon, René Doyon, Mohammed El Mufti, Emma Esparza-Borges, Zahra Essack, Akihiko Fukui, Tianjun Gan, Kaz Gary, Mourad Ghachoui, Michaël Gillon, Eric Girardin, Ana Glidden, Erica J. Gonzales, Pere Guerra, Elliott P. Horch, Krzysztof G. Hełminiak, Andrew W. Howard, Daniel Huber, Jonathan M. Irwin, Giovanni Isopi, Emmanuël Jehin, Taiki Kagetani, Stephen R. Kane, Kiyoe Kawauchi, John F. Kielkopf, Pablo Lewin, Lindy Luker, Michael B. Lund, Franco Mallia, Shude Mao, Bob Massey, Rachel A. Matson, Ismael Mireles, Mayuko Mori, Felipe Murgas, Norio Narita, Tanner O’Dwyer, Erik A. Petigura, Alex S. Polanski, Francisco J. Pozuelos, Enric Palle, Hannu Parviainen, Peter P. Plavchan, Howard M. Relles, Paul Robertson, Mark E. Rose, Pamela Rowden, Arpita Roy, Arjun B. Savel, Joshua E. Schlieder, Chloe Schnaible, Richard P. Schwarz, Ramatholo Sefako, Aleksandra Selezneva, Brett Skinner, Chris Stockdale, Ivan A. Strakhov, Thiam-Guan Tan, Guillermo Torres, René Tronsgaard, Joseph D. Twicken, David Vermilion, Ian A. Waite, Bradley Walter, Gavin Wang, Carl Ziegler, and Yujie Zou

Published
2022
Full Text
View/download PDF

11. The Pluto Energetic Particle Spectrometer Science Investigation (PEPSSI) on the New Horizons Mission

Author

McNutt, Ralph L., Jr., Livi, Stefano A., Gurnee, Reid S., Hill, Matthew E., Cooper, Kim A., Andrews, G. Bruce, Keath, Edwin P., Krimigis, Stamatios M., Mitchell, Donald G., Tossman, Barry, Bagenal, Fran, Boldt, John D., Bradley, Walter, Devereux, William S., Ho, George C., Jaskulek, Stephen E., LeFevere, Thomas W., Malcom, Horace, Marcus, Geoffrey A., Hayes, John R., Moore, G. Ty, Perry, Mark E., Williams, Bruce D., Wilson, Paul, IV, Brown, Lawrence E., Kusterer, Martha B., Vandegriff, Jon D., and Russell, C. T., editor

Published
2009
Full Text
View/download PDF

12. The X-ray Spectrometer on the MESSENGER Spacecraft

Author

Schlemm, Charles E., II, Starr, Richard D., Ho, George C., Bechtold, Kathryn E., Hamilton, Sarah A., Boldt, John D., Boynton, William V., Bradley, Walter, Fraeman, Martin E., Gold, Robert E., Goldsten, John O., Hayes, John R., Jaskulek, Stephen E., Rossano, Egidio, Rumpf, Robert A., Schaefer, Edward D., Strohbehn, Kim, Shelton, Richard G., Thompson, Raymond E., Trombka, Jacob I., Williams, Bruce D., Domingue, D. L., editor, and Russell, C. T., editor

Published
2007
Full Text
View/download PDF

13. Using Agricultural Waste to Create More Environmentally Friendly and Affordable Products and Help Poor Coconut Farmers

Author

Bradley Walter L. and Conroy Sean

Subjects
coconut shell filler, coir non-woven, polypropylene, composites, Environmental sciences, GE1-350
Abstract

Each year, 64 000 000 000 coconuts are harvested around the world. The coconut water, coconut milk and/are coconut oil are produced from the coconut, leaving behind the coconut shells and the coconut husks, which are not well utilized. Exciting new ways to utilized coconut shell powder as function filler in engineering plastic such as polypropylene or polyethylene and to utilize coir fiber from the husk with polypropylene in non-woven fabric composites. These application demonstrate that the resulting environmental friendly composite materials have enhanced mechanical properties at a reduced cost.

Published
2019
Full Text
View/download PDF

14. The Effect of Coconut Shell Powder as Functional Filler in Polypropylene during Compounding and Subsequent Molding

Author

Kirby Matt, Lewis Benjamin, Peterson Benjamin, Anggono Juliana, and Bradley Walter

Subjects
functional filler, impact strength, natural filler reinforcement, polymeric composites, rheological behavior, Environmental sciences, GE1-350
Abstract

Fine powder produced from coconut shells (CSP) has been found to be excellent functional filler in polypropylene, significantly increasing flexural and tensile moduli, slightly increasing tensile strength, and good retention of Izod impact strength at weight percentages less than 20 %. The research presented in this paper explores the temperature processing window for coconut shell powder filled polypropylene and the change in the rheological behavior of the polypropylene due to the addition of CSP as functional filler in this processing temperature window. The reason for the simultaneous increase in flexural modulus, tensile strength, and good retention of Izod impact behavior is also investigated

Published
2019
Full Text
View/download PDF

15. Airborne lead and polychlorinated biphenyls (PCBs) are associated with amyotrophic lateral sclerosis (ALS) risk in the U.S

Author

Andrew, Angeline, primary, Zhou, Jie, additional, Gui, Jiang, additional, Harrison, Antoinette, additional, Shi, Xun, additional, Li, Meifang, additional, Guetti, Bart, additional, Nathan, Ramaa, additional, Tischbein, Maeve, additional, Pioro, Erik, additional, Stommel, Elijah, additional, and Bradley, Walter, additional

Published
2022
Full Text
View/download PDF

17. HIV-1 Heterogeneity and Cytokines : Neuropathogenesis

Author

Shapshak, Paul, Nagano, Isao, Xin, Keqin, Bradley, Walter, McCoy, Clyde B., Sun, Nora C. J., Stewart, Renée V., Yoshioka, Masaru, Petito, Carol, Goodkin, Karl, Douyon, Richard, Srivastava, Ashok K., Crandall, Keith A., Sharp, Burt M., editor, Eisenstein, Toby K., editor, Madden, John J., editor, and Friedman, Herman, editor

Published
1995
Full Text
View/download PDF

18. ALS risk factors: Industrial airborne chemical releases

Author

Andrew, Angeline, primary, Zhou, Jie, additional, Gui, Jiang, additional, Shi, Xun, additional, Li, Meifang, additional, Harrison, Antoinette, additional, Guetti, Bart, additional, Nathan, Ramaa, additional, Butt, Tanya, additional, Peipert, Daniel, additional, Tischbein, Maeve, additional, Pioro, Erik P., additional, Stommel, Elijah, additional, and Bradley, Walter, additional

Published
2022
Full Text
View/download PDF

27. The Pluto Energetic Particle Spectrometer Science Investigation (PEPSSI) on the New Horizons Mission

Author

McNutt, Jr., Ralph L., Livi, Stefano A., Gurnee, Reid S., Hill, Matthew E., Cooper, Kim A., Andrews, G. Bruce, Keath, Edwin P., Krimigis, Stamatios M., Mitchell, Donald G., Tossman, Barry, Bagenal, Fran, Boldt, John D., Bradley, Walter, Devereux, William S., Ho, George C., Jaskulek, Stephen E., LeFevere, Thomas W., Malcom, Horace, Marcus, Geoffrey A., Hayes, John R., Moore, G. Ty, Perry, Mark E., Williams, Bruce D., Wilson, IV, Paul, Brown, Lawrence E., Kusterer, Martha B., and Vandegriff, Jon D.

Published
2008
Full Text
View/download PDF

30. The X-Ray Spectrometer on the MESSENGER Spacecraft

Author

Schlemm, II, Charles E., Starr, Richard D., Ho, George C., Bechtold, Kathryn E., Hamilton, Sarah A., Boldt, John D., Boynton, William V., Bradley, Walter, Fraeman, Martin E., Gold, Robert E., Goldsten, John O., Hayes, John R., Jaskulek, Stephen E., Rossano, Egidio, Rumpf, Robert A., Schaefer, Edward D., Strohbehn, Kim, Shelton, Richard G., Thompson, Raymond E., Trombka, Jacob I., and Williams, Bruce D.

Published
2007
Full Text
View/download PDF

31. Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial

Author

David Cella, Suresh S. Ramalingam, Lynne I. Wagner, Josephine Feliciano, Charu Aggarwal, James L. Wade, Gordan Srkalovic, Nisha Mohindra, Laurie E. McLouth, Fengmin Zhao, Suzanne E. Dahlberg, Bradley Walter Lash, Ticiana A. Leal, Joseph W. Leach, and Taofeek K. Owonikoko

Subjects
0301 basic medicine, Male, Cancer Research, Lung Neoplasms, law.invention, Carboplatin, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Etoposide, chemotherapy‐induced peripheral neuropathy, veliparib, Original Research, Aged, 80 and over, Peripheral Nervous System Diseases, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Oncology, Tolerability, 030220 oncology & carcinogenesis, Female, medicine.drug, Randomization, Veliparib, Gynecologic oncology, Placebo, lcsh:RC254-282, Medication Adherence, 03 medical and health sciences, medicine, Humans, Radiology, Nuclear Medicine and imaging, Patient Reported Outcome Measures, tolerability, Aged, business.industry, Neurotoxicity, Clinical Cancer Research, small cell, medicine.disease, Small Cell Lung Carcinoma, 030104 developmental biology, chemistry, Cancer research, Benzimidazoles, business, patient‐reported outcomes
Abstract

Objectives The ECOG‐ACRIN Cancer Research Group trial E2511 recently demonstrated a potential benefit for the addition of veliparib to cisplatin‐etoposide (CE) in patients with extensive stage small cell lung cancer (ES‐SCLC) in a phase II randomized controlled trial. Secondary trial endpoints included comparison of the incidence and severity of neurotoxicity, hypothesized to be lower in the veliparib arm, and tolerability of the addition of veliparib to CE. Physician‐rated and patient‐reported neurotoxicity was also compared. Materials and Methods Patients randomized to veliparib plus CE (n = 64) or placebo plus CE (n = 64) completed the 11‐item Functional Assessment of Cancer Therapy Gynecologic Oncology Group Neurotoxicity (questionnaire pre‐treatment, end of cycle 4 [ie 3 months after randomization] and 3 months post‐treatment [ie 6‐months]). Adherence analysis was based on treatment forms. Results and Conclusion No significant differences in mean or magnitude of change in neurotoxicity scores were observed between treatment arms at any time point. However, patients in the placebo arm reported worsening neurotoxicity from baseline to 3‐months (M difference = −1.5, P = .045), compared to stable neurotoxicity in the veliparib arm (M difference = −0.2, P = .778). Weakness was the most common treatment‐emergent (>50%) and moderate to severe (>16%) symptom reported, but did not differ between treatment arms. The proportion of adherence to oral therapy in the overall sample was 75%. Three percent of patients reported clinically significant neurotoxicity that was not captured by physician assessment. Neurotoxicity scores were not different between treatment arms. The addition of veliparib to CE appeared tolerable, though weakness should be monitored. ClinicalTrials.gov Identifier NCT01642251., We examined patient‐reported tolerability of the addition of a PARP inhibitor, veliparib, to cisplatin‐etoposide for treatment of extensive stage small cell lung cancer in randomized controlled trial E2511. The addition of veliparib to cisplatin‐etoposide was tolerable according to a patient‐reported outcome and adherence. Future studies should assess whether veliparib may have a protective effect against chemotherapy‐induced peripheral neuropathy.

Published
2020

34. The Incidence of Amyotrophic Lateral Sclerosis in Ohio 2016–2018: The Ohio Population-Based ALS Registry

Author

Andrew, Angeline S., primary, Pioro, Erik P., additional, Li, Meifang, additional, Shi, Xun, additional, Gui, Jiang, additional, Stommel, Elijah W., additional, Butt, Tanya H., additional, Peipert, Daniel, additional, Henegan, Patricia, additional, Tischbein, Maeve, additional, Cazzolli, Pamela, additional, Novak, John, additional, Quick, Adam, additional, Pugar, K. Doug, additional, Sawlani, Komal, additional, Katirji, Bashar, additional, Hayes, Todd A., additional, Horton, D. Kevin, additional, Mehta, Paul, additional, and Bradley, Walter G., additional

Published
2021
Full Text
View/download PDF

35. Long-term survival analysis of masitinib in amyotrophic lateral sclerosis

Author

Mora, Jesus S., primary, Bradley, Walter G., additional, Chaverri, Delia, additional, Hernández-Barral, María, additional, Mascias, Javier, additional, Gamez, Josep, additional, Gargiulo-Monachelli, Gisella M., additional, Moussy, Alain, additional, Mansfield, Colin D., additional, Hermine, Olivier, additional, and Ludolph, Albert C., additional

Published
2021
Full Text
View/download PDF

39. Contributors

Author

Allen, Jeffrey C., primary, Alshehri, Abdulrahim M., additional, Amato, Anthony A., additional, Aminoff, Michael J., additional, Ashwal, Stephen, additional, Asir, Alparslan, additional, Babikian, Viken L., additional, Baehring, Joachim M., additional, Balcer, Laura J., additional, Baloh, Robert W., additional, Bartleson, J.D., additional, Batchelor, Tracy T., additional, Berger, Joseph R., additional, Bethoux, Francois, additional, Bhatia, Rita G., additional, Biller, José, additional, Bird, Thomas D., additional, Black, David F., additional, Blackham, Kristine, additional, Blackman, Samuel C., additional, Boes, Christopher J., additional, Bosch, E. Peter, additional, Boulis, Nicholas, additional, Bowen, Brian C., additional, Bradley, Walter G., additional, Bramlett, Helen M., additional, Brooke, Michael H., additional, Bruni, Joseph, additional, Byrne, Thomas N., additional, Capobianco, David J., additional, Chad, David A., additional, Chitnis, Tanuja, additional, Chokroverty, Sudhansu, additional, Ciaverella, David P., additional, Cooper, Paul E., additional, Cutrer, F. Michael, additional, Dalmau, Josep, additional, Daroff, Robert B., additional, DasGupta, Ranan, additional, DeKosky, Steven T., additional, Deshaies, Eric M., additional, Dietrich, W. Dalton, additional, Dobkin, Bruce H., additional, Dodick, David W., additional, Duff, Kevin, additional, Emerson, Ronald G., additional, Fenichel, Gerald M., additional, Fernandes Filho, J. Americo, additional, Fessler, Richard G., additional, Finelli, Pasquale F., additional, Flores-Sarnat, Laura, additional, Fowler, Clare J., additional, Gala, Vishal C., additional, Garza, Ivan, additional, Geldmacher, David S., additional, Gengo, Fran M., additional, Giglio, Pierre, additional, Gilbert, Mark, additional, Goldsmith, Ian L., additional, Golomb, Meredith R., additional, Rothi, Leslie J. Gonzalez, additional, Hallet, Mark, additional, Hamati, Aline I., additional, Hamilton, Ronald L., additional, Harati, Yadollah, additional, Heffner, Reid R., additional, Heilman, Kenneth M., additional, Heros, Deborah O., additional, Heros, Roberto C., additional, Hill, Alan, additional, Hirano, Michio, additional, Hochberg, Fred H., additional, Howard, James F., additional, Hsu, Daniel, additional, Islam, Monica P., additional, Jankovic, Joseph, additional, Kalita, Jayantee, additional, Kase, Carlos S., additional, Katirji, Bashar, additional, Kaufer, Daniel I., additional, Kerber, Kevin A., additional, Kerchner, Geoffrey A., additional, Khoury, Samia J., additional, Kim, Dae-Hyun, additional, Kirshner, Howard S., additional, Kurtzke, John F., additional, Lang, Anthony E., additional, Lavin, Patrick J.M., additional, Lenz, Robert A., additional, Lesser, Ronald P., additional, Linfante, Italo, additional, Lockwood, Alan H., additional, Lopez, Oscar L., additional, Alberola, Roberto López, additional, Louis, David N., additional, Love, Betsy B., additional, Lublin, Fred D., additional, Mair, Robert G., additional, Marion, Donald W., additional, McMurtray, Aaron, additional, Mehndiratta, Man Mohan, additional, Mendez, Mario F., additional, Michaud, Dominique S., additional, Michelson, David J., additional, Miller, Aaron E., additional, Misra, Usha Kant, additional, Misulis, Karl E., additional, Mitsumoto, Hiroshi, additional, Mizrahi, Eli M., additional, Moraes, Carlos T., additional, Morrison, David, additional, Murray, Brian, additional, Murray, Evan D., additional, Nass, Ruth, additional, Nehl, Carissa, additional, Panagariya, Ashok, additional, Pastores, Gregory M., additional, Paulsen, Jane S., additional, Pedley, Timothy A., additional, Perry, Arie, additional, Pestronk, Alan, additional, Pfeiffer, Ronald F., additional, Prasad, Sashank, additional, Preston, David C., additional, Price, Bruce H., additional, Ptáček, Louis J., additional, Rabinstein, Alejandro A., additional, Ratcheson, Robert A., additional, Remler, Bernd F., additional, Roach, E. Steve, additional, Robertson, David, additional, Robinson, Jenice A., additional, Ronthal, Michael, additional, Rosenbaum, Richard B., additional, Rosenberg, Gary A., additional, Rosenfeld, Myrna R., additional, Ross, Gail, additional, Rucker, Janet C., additional, Sadowski, Martin, additional, Saigal, Gaurav, additional, Sanders, Donald B., additional, Sandhu, Johnny S., additional, Sarnat, Harvey B., additional, Savani, Aman A., additional, Schiff, David, additional, Schmidley, James W., additional, Schneck, Michael J., additional, Schumacher, James M., additional, Selman, Warren R., additional, Shaner, D. Malcolm, additional, Shannon, Kathleen M., additional, Shapiro, Barbara E., additional, Simon, Roger P., additional, Sklar, Evelyn M.L., additional, So, Yuen T., additional, Sohn, Young H., additional, Solbrig, Marylou V., additional, Stoessl, A. Jon, additional, Subramony, S.H., additional, Swanson, Jerry W., additional, Tapscott, Stephen J., additional, Tarr, Robert W., additional, Tegeler, Charles H., additional, Thompson, Philip D., additional, Tomsak, Robert L., additional, Trescher, William H., additional, Tsao, Bryan, additional, Tyler, Kenneth L., additional, Valenstein, Edward, additional, Verma, Ashok, additional, Voloschin, Alfredo D., additional, Voyadzis, Jean-Marc, additional, Wakhloo, Ajay K., additional, Wall, Michael, additional, Wallin, Mitchell T., additional, Watson, Robert T., additional, Waxman, Stephen G., additional, Wen, Patrick, additional, Wijdicks, Eelco F.M., additional, Wisniewski, Thomas, additional, Wolk, David A., additional, and Zhou, YiLi, additional

Published
2008
Full Text
View/download PDF

46. Risk factors for amyotrophic lateral sclerosis: A regional United States case‐control study

Author

Andrew, Angeline S., primary, Bradley, Walter G., additional, Peipert, Daniel, additional, Butt, Tanya, additional, Amoako, Kwadwo, additional, Pioro, Erik P., additional, Tandan, Rup, additional, Novak, John, additional, Quick, Adam, additional, Pugar, K. Doug, additional, Sawlani, Komal, additional, Katirji, Bashar, additional, Hayes, Todd A., additional, Cazzolli, Pamela, additional, Gui, Jiang, additional, Mehta, Paul, additional, Horton, D. Kevin, additional, and Stommel, Elijah W., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results